No Data
No Data
Strategic Partnership With Kyowa Kirin Strengthens Kura Oncology's Financial and Commercial Position
Three key points to focus on in the later session - semiconductor stocks fell, momentarily dropping below 38,000 yen.
During the afternoon trade on the 21st, attention should be paid to the following three points. ・The Nikkei Average continues to decline, the drop in semiconductor stocks caused it to temporarily fall below 38,000 yen. ・The dollar-yen is struggling to lower, resurfacing around 155 yen. ・The top contributor to the decline is Fast Retailing <9983>, and the second is Advantest <6857>. ■ The Nikkei Average continues to decline, the drop in semiconductor stocks caused it to temporarily fall below 38,000 yen. The Nikkei Average is down by 319.12 yen (-0.83%) at 38,033.22 yen (volume approximately 0.8 billion 30 million shares).
Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration
Kura Oncology and Kyowa Kirin: Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
Kyowa Kirin's Attributable Profit Gains Over 4% in Nine Months to September
No Data
No Data